Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Arbitration panel rules in favor of Lilly in complaint filed by Adocia

A Chicago-based arbitration panel ruled in favor of Eli Lilly and Company in a claim filed by Adocia S.A. over the companies’ prior collaboration on a rapid-acting insulin.

Read More »

Edwards Lifesciences recalls delivery system for Sapien heart valves

Medical device maker Edwards Lifesciences Corp. is recalling the company’s Sapien 3 Ultra delivery system after burst balloons during implantation led to several injuries and a death, said the U.S. Food and Drug Administration on Thursday.

Read More »

First Commercial Platform with Mutations and CNV Insights from the Same Cell on Single Platform

San Francisco-based Mission Bio Inc. launched an addition to the company’s Tapestri Platform that provides it the ability to track the full scope genomics of cancer in terms of single-cell capabilities.

Read More »

Novo Nordisk and Mylan Battle Over Generic Versions of Victoza

Denmark’s Novo Nordisk filed a lawsuit in a Delaware district court against generic drugmaker Mylan.

Read More »

NuCana’s Pancreatic Cancer Trial Halted Due to Futility

Shares of U.K.-based NuCana were down more than 21 percent after the company announced suspended enrollment of patients in a late-stage pancreatic cancer study.

Read More »

Pfizer invests $500 million in expanding gene therapy facility

Pfizer Inc. is investing $500 million to expand a manufacturing facility in Sanford, North Carolina, that plays a central role in the company’s efforts to become a major player in gene therapy.

Read More »

Fitbit eyes one million new users in Singapore health scheme

Fitbit Inc. won a contract with the Singapore government to provide fitness trackers and services to up to one million of the country’s citizens as part of a health initiative that begins in October 2019.

Read More »

New Campaign Focuses on Fighting Superbugs

Leading scientists, public policy experts and biotech industry leaders joined forces to launch “Working to Fight AMR,” a coalition working to raise public awareness of the growing threat posed by antimicrobial resistance.

Read More »

Sarepta shares sink 14% after shock FDA rejection

Shares of Sarepta Therapeutics Inc. plunged 14 percent after the U.S. health regulator, in an unexpected move, declined to approve the drugmaker’s newest treatment for a muscle-wasting disorder.

Read More »

Elanco to become No. 2 in animal health with $7.6 billion Bayer deal

Elanco Animal Health agreed to buy Bayer’s veterinary drugs unit in a cash and stock deal valued at $7.6 billion, creating the second-largest maker of medicines for pets and livestock and expanding Elanco’s reach online.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

October 2019 Focus: Top 50 Company Profiles & Financials, Outcomes Creativity Index, and more!


Ad Right Bottom